Telemetry Investments’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$47K Buy
+4,800
New +$53.1K 0.07% 103
2021
Q4
Sell
-3,667
Closed -$177K 181
2021
Q3
$177K Buy
+3,667
New +$179K 0.24% 108
2020
Q4
Sell
-1,225
Closed -$74K 92
2020
Q3
$74K Sell
1,225
-133
-10% -$6.77K 0.16% 69
2020
Q2
$55K Hold
1,358
0.15% 63
2020
Q1
$39K Buy
+1,358
New +$45.1K 0.14% 51

Other funds holding FBIO

Telemetry Investments's FBIO Position: Q4 2022 in Review

Telemetry Investments opened a new position in Fortress Biotech (FBIO) in Q4 2022: 4,800 shares worth $47K. The stake represents 0.07% of the portfolio and ranks #103 among its holdings. This is a return to the name: Telemetry Investments previously reported a position in FBIO as recently as Q3 2021.

Telemetry Investments first reported a position in FBIO in Q1 2020 and has held it in 5 quarters since. The position peaked at $177K in Q3 2021. 49 funds tracked by Wall St. Rank hold FBIO as of Q4 2022.

  • Telemetry Investments held 4,800 shares of Fortress Biotech worth $47K as of Q4 2022.
  • Fortress Biotech was a new Telemetry Investments position in Q4 2022.
  • Fortress Biotech made up 0.07% of Telemetry Investments's portfolio in Q4 2022, its #103 holding.
  • Telemetry Investments first reported a position in Fortress Biotech in Q1 2020 and has held it in 5 quarters since.
  • Telemetry Investments's Fortress Biotech position peaked at $177K in Q3 2021.
  • 49 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.